메뉴 건너뛰기




Volumn 40, Issue 3, 2005, Pages 86-90

Exenatide: A novel incretin mimetic hormone for the treatment of type 2 diabetes

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; AMYLIN; BIGUANIDE DERIVATIVE; EXENDIN 4; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE RECEPTOR; GLUCOSE; HORMONE ANALOG; INCRETIN; INCRETIN MIMETIC HORMONE; INSULIN; MEGLITINIDE; METFORMIN; NEW DRUG; ORAL ANTIDIABETIC AGENT; RECEPTOR; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG;

EID: 16244409838     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (14)

References (14)
  • 2
    • 79960614571 scopus 로고    scopus 로고
    • American Diabetes Association. National Diabetes Fact Sheet. Available at: http://www. diabetes.org/diabetes-statistics/national-diabetes-fact-sheet. jsp. Accessed February 15, 2005.
    • National Diabetes Fact Sheet
  • 3
    • 0032972676 scopus 로고    scopus 로고
    • 1999 Racial and ethnic differences in glycemic control of adults with type 2 diabetes
    • Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. 1999 Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care. 1999;22:403-408.
    • (1999) Diabetes Care , vol.22 , pp. 403-408
    • Harris, M.I.1    Eastman, R.C.2    Cowie, C.C.3    Flegal, K.M.4    Eberhardt, M.S.5
  • 4
    • 0026648961 scopus 로고
    • Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas
    • Eng J, Kleinman WA, Singh L, Singh G, Raufman JP. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem. 1992;15;267:7402-7405.
    • (1992) J Biol Chem , vol.267 , Issue.11 , pp. 7402-7405
    • Eng, J.1    Kleinman, W.A.2    Singh, L.3    Singh, G.4    Raufman, J.-P.5
  • 5
    • 0347360186 scopus 로고    scopus 로고
    • Pharmacology of exenatide (synthetic exendin-4): A potential therapeutic for improved glycemic control of type 2 diabetes
    • Nielsen LL,Young AA, Parkes DG. Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes. Regulatory Peptides. 2004;117: 77-88.
    • (2004) Regulatory Peptides , vol.117 , pp. 77-88
    • Nielsen, L.L.1    Young, A.A.2    Parkes, D.G.3
  • 6
    • 0028803336 scopus 로고
    • Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH sub 2-terminus in type II diabetic patients and in healthy subjects
    • Deacon CF, Nauck MA, Toft-Nielsen M, Pridal L, Willms B, Holst JJ. Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH sub 2-terminus in type II diabetic patients and in healthy subjects. Diabetes. 1995;44:1126-1131.
    • (1995) Diabetes , vol.44 , pp. 1126-1131
    • Deacon, C.F.1    Nauck, M.A.2    Toft-Nielsen, M.3    Pridal, L.4    Willms, B.5    Holst, J.J.6
  • 7
    • 0037850667 scopus 로고    scopus 로고
    • Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes
    • Fineman MS, Bicsak TA, Shen LZ, et al. Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes. Diabetes Care. 2003;26:2370-2377.
    • (2003) Diabetes Care , vol.26 , pp. 2370-2377
    • Fineman, M.S.1    Bicsak, T.A.2    Shen, L.Z.3
  • 8
    • 0031936954 scopus 로고    scopus 로고
    • Glucagon-like peptides
    • Drucker DJ. Glucagon-like peptides. Diabetes. 1998;47:159-169.
    • (1998) Diabetes , vol.47 , pp. 159-169
    • Drucker, D.J.1
  • 9
    • 0038497464 scopus 로고    scopus 로고
    • Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes
    • Kolterman OG, Buse JB, Fineman MS, et al. Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab. 2003;88:3082-3089.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 3082-3089
    • Kolterman, O.G.1    Buse, J.B.2    Fineman, M.S.3
  • 11
    • 7444243454 scopus 로고    scopus 로고
    • Effects of exenatide (synthetic exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
    • June 4-8 ; Orlando, Fla. Abstract 6-LB
    • DeFronzo R, Ratner R, Han J, Kim D, Fineman M, Baron A. Effects of exenatide (synthetic exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes [abstract]. Presented at: American Diabetes Association 64th Annual Scientific Sessions; June 4-8, 2004; Orlando, Fla. Abstract 6-LB.
    • (2004) American Diabetes Association 64th Annual Scientific Sessions
    • DeFronzo, R.1    Ratner, R.2    Han, J.3    Kim, D.4    Fineman, M.5    Baron, A.6
  • 12
    • 7444228521 scopus 로고    scopus 로고
    • Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
    • Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD, and the Exenatide-113 Clinical Study Group. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Diabetes Care. 2004;27:2628-2635.
    • (2004) Diabetes Care , vol.27 , pp. 2628-2635
    • Buse, J.B.1    Henry, R.R.2    Han, J.3    Kim, D.D.4    Fineman, M.S.5    Baron, A.D.6
  • 13
    • 19444367290 scopus 로고    scopus 로고
    • Effects of exenatide (exendin-4) on glycemic control and weight in patients with type 2 diabetes treated with metformin and a sulfonylurea
    • June 4-8 ; Orlando, Fla. Abstract 10-LB
    • Kendall DM, Riddle MC, Dongliang Z, Kim DD, Fineman MS, Baron AD. Effects of exenatide (exendin-4) on glycemic control and weight in patients with type 2 diabetes treated with metformin and a sulfonylurea. Presented at: American Diabetes Association 64th Annual Scientific Sessions; June 4-8, 2004; Orlando, Fla. Abstract 10-LB.
    • (2004) American Diabetes Association 64th Annual Scientific Sessions
    • Kendall, D.M.1    Riddle, M.C.2    Dongliang, Z.3    Kim, D.D.4    Fineman, M.S.5    Baron, A.D.6
  • 14
    • 0033578476 scopus 로고    scopus 로고
    • Pharmacologic therapy for type 2 diabetes mellitus
    • DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med. 1999;131: 281-303.
    • (1999) Ann Intern Med , vol.131 , pp. 281-303
    • DeFronzo, R.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.